A Study of Toripalimab or Placebo Plus Chemotherapy as Treatment in Early Stage NSCLC
Condition: Stage IIIA Non-small Cell Lung Cancer Interventions: Drug: Toripalimab + platinum-based doublet chemotherapy; Drug: Placebo + platinum-based doublet chemotherapy Sponsor: Shanghai Junshi Bioscience Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Non-Small Cell Lung Cancer | Research | Study